BlackRock’s VanEck Biotech ETF BBH Stock Holding History

BlackRock’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31K	Hold	165	–	–	﹤0.01%	5229
2025 Q4	$31.2K	Buy	165 +55	+50%	+$10.2K	﹤0.01%	5145
2025 Q3	$18.2K	Buy	110 +40	+57%	+$6.52K	﹤0.01%	5157
2025 Q2	$10.7K	Buy	+70	New	+$10.4K	﹤0.01%	5217

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

BlackRock's BBH Position: Q1 2026 in Review

BlackRock held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 165 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #5229.

BlackRock first reported a position in BBH in Q2 2025 and has held it in 4 quarters since. The position peaked at $31.2K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

BlackRock held 165 shares of VanEck Biotech ETF worth $31K as of Q1 2026.
BlackRock left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #5229 holding.
BlackRock first reported a position in VanEck Biotech ETF in Q2 2025 and has held it in 4 quarters since.
BlackRock's VanEck Biotech ETF position peaked at $31.2K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.